Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
13 hedge funds and large institutions have $1.58M invested in Yield10 Bioscience, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
8% more funds holding
Funds holding: 12 → 13 (+1)
6% more capital invested
Capital invested by funds: $1.5M → $1.58M (+$85K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$40.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$32.6K |
| 3 |
Renaissance Technologies
New York
|
+$19K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$14.9K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.72K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$36K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9.51K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
YTEN Hedge Fund Activity: Q3 2018 in Review
13 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q3 2018, worth a combined $1.58M — up 5.7% from $1.5M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new YTEN positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $40.8K. The largest seller was Virtu Financial, exiting entirely with an estimated $36K sold.
- 13 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q3 2018, up from 12 in Q2 2018.
- Funds reported $1.58M of Yield10 Bioscience, Inc. Common Stock stock for Q3 2018, up 5.7% quarter-over-quarter.
- 4 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q3 2018 and 3 closed out, a net change of +1 holder.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q3 2018 was Citadel Advisors, an estimated $40.8K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q3 2018 was Virtu Financial, an estimated $36K sold.
Based on aggregated 13F filings for Q3 2018.